Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huichun Tian

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Critical Reviews in Oncology/Hematology|November 30, 2023
Treatment of acral and mucosal melanoma: Current and emerging targeted therapiesJiaran Zhang, Huichun Tian, Lili Mao, et al.
Materials (Basel, Switzerland)|December 17, 2024
4D Printing Self-Sensing and Load-Carrying Smart ComponentsYi Qin, Jianxin Qiao, Shuai Chi, et al.
Cancer Investigation|May 23, 2025
Clinical Characteristics and Impact on Prognosis of Melanoma Accompanied by Multiple Primary Malignancies: A Retrospective AnalysisHuichun Tian, Jiaran Zhang, Lili Mao, et al.
BMC Medicine|July 2, 2026
Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 studyJuan Li, Huichun Tian, Huayan Xu, et al.
Cancer Management and Research|May 7, 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral MelanomaJiaran Zhang, Huichun Tian, Lili Mao, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Critical Reviews in Oncology/Hematology|November 30, 2023
Treatment of acral and mucosal melanoma: Current and emerging targeted therapiesJiaran Zhang, Huichun Tian, Lili Mao, et al.
Materials (Basel, Switzerland)|December 17, 2024
4D Printing Self-Sensing and Load-Carrying Smart ComponentsYi Qin, Jianxin Qiao, Shuai Chi, et al.
Cancer Investigation|May 23, 2025
Clinical Characteristics and Impact on Prognosis of Melanoma Accompanied by Multiple Primary Malignancies: A Retrospective AnalysisHuichun Tian, Jiaran Zhang, Lili Mao, et al.
BMC Medicine|July 2, 2026
Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 studyJuan Li, Huichun Tian, Huayan Xu, et al.
Cancer Management and Research|May 7, 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral MelanomaJiaran Zhang, Huichun Tian, Lili Mao, et al.
Pageof 1